This inventor holds 1 USPTO granted patent. Top assignee: Daewon Pharm., Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations in Pharmaceutical Formulation by Se-il Sohn
Introduction
Se-il Sohn is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of oral medications. His work focuses on improving the efficacy and stability of pharmaceutical compounds.
Latest Patents
Se-il Sohn holds a patent for an oral pharmaceutical formulation of pelubiprofen with an improved dissolution rate and stability. This innovative formulation enhances the dissolution rate of pelubiprofen, leading to high bioavailability and rapid pharmacological effects. Additionally, the formulation exhibits high stability, minimizing the generation of related compounds during storage.
Career Highlights
Se-il Sohn is associated with Daewon Pharm., Co., Ltd., where he continues to develop and refine pharmaceutical formulations. His expertise in this area has positioned him as a valuable asset to the company and the industry.
Collaborations
Se-il Sohn collaborates with talented coworkers, including Joungmin Han and Chankyu Jeoung. Their combined efforts contribute to the advancement of pharmaceutical innovations.
Conclusion
Se-il Sohn's work in pharmaceutical formulation exemplifies the importance of innovation in enhancing drug efficacy and stability. His contributions are paving the way for improved therapeutic options in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile